Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

SARS treatment. Interferon shows promise in monkeys.

Identifieur interne : 005116 ( Main/Exploration ); précédent : 005115; suivant : 005117

SARS treatment. Interferon shows promise in monkeys.

Auteurs : Martin Enserink

Source :

RBID : pubmed:14988528

Descripteurs français

English descriptors


DOI: 10.1126/science.303.5662.1273a
PubMed: 14988528


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">SARS treatment. Interferon shows promise in monkeys.</title>
<author>
<name sortKey="Enserink, Martin" sort="Enserink, Martin" uniqKey="Enserink M" first="Martin" last="Enserink">Martin Enserink</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:14988528</idno>
<idno type="pmid">14988528</idno>
<idno type="doi">10.1126/science.303.5662.1273a</idno>
<idno type="wicri:Area/PubMed/Corpus">002F36</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002F36</idno>
<idno type="wicri:Area/PubMed/Curation">002F36</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002F36</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A78</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A78</idno>
<idno type="wicri:Area/Ncbi/Merge">000630</idno>
<idno type="wicri:Area/Ncbi/Curation">000630</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000630</idno>
<idno type="wicri:Area/Main/Merge">005488</idno>
<idno type="wicri:Area/Main/Curation">005116</idno>
<idno type="wicri:Area/Main/Exploration">005116</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">SARS treatment. Interferon shows promise in monkeys.</title>
<author>
<name sortKey="Enserink, Martin" sort="Enserink, Martin" uniqKey="Enserink M" first="Martin" last="Enserink">Martin Enserink</name>
</author>
</analytic>
<series>
<title level="j">Science (New York, N.Y.)</title>
<idno type="eISSN">1095-9203</idno>
<imprint>
<date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antibodies, Monoclonal (therapeutic use)</term>
<term>Antiviral Agents (administration & dosage)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Humans</term>
<term>Interferon alpha-2</term>
<term>Interferon-alpha (administration & dosage)</term>
<term>Interferon-alpha (therapeutic use)</term>
<term>Lung (pathology)</term>
<term>Macaca fascicularis</term>
<term>Polyethylene Glycols</term>
<term>Recombinant Proteins</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (immunology)</term>
<term>Severe Acute Respiratory Syndrome (drug therapy)</term>
<term>Severe Acute Respiratory Syndrome (pathology)</term>
<term>Severe Acute Respiratory Syndrome (prevention & control)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Anticorps monoclonaux (usage thérapeutique)</term>
<term>Antiviraux (administration et posologie)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Humains</term>
<term>Interféron alpha (administration et posologie)</term>
<term>Interféron alpha (usage thérapeutique)</term>
<term>Macaca fascicularis</term>
<term>Polyéthylène glycols</term>
<term>Poumon (anatomopathologie)</term>
<term>Protéines recombinantes</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (anatomopathologie)</term>
<term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antiviral Agents</term>
<term>Interferon-alpha</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antibodies, Monoclonal</term>
<term>Antiviral Agents</term>
<term>Interferon-alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Antiviraux</term>
<term>Interféron alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Poumon</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Lung</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Anticorps monoclonaux</term>
<term>Antiviraux</term>
<term>Interféron alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>Interferon alpha-2</term>
<term>Macaca fascicularis</term>
<term>Polyethylene Glycols</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Humains</term>
<term>Macaca fascicularis</term>
<term>Polyéthylène glycols</term>
<term>Protéines recombinantes</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Enserink, Martin" sort="Enserink, Martin" uniqKey="Enserink M" first="Martin" last="Enserink">Martin Enserink</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005116 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005116 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:14988528
   |texte=   SARS treatment. Interferon shows promise in monkeys.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:14988528" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021